In a research report released Tuesday, Canaccord analyst John Newman reiterated a Buy rating on Regeneron Pharmaceuticals Inc (NASDAQ:REGN) with a price target of …
Amedica Corporation (NASDAQ:AMDA) shares plummeted more than -35% in pre-market trading down to $0.51 after the company announced preliminary second quarter financial results.
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA (ADR)(NYSE:SNY) have entered into a new global collaboration to discover, develop and commercialize new antibody cancer treatments …
In a research report issued today, Brean Capital analyst Jonathan Aschoff offered some commentary on Regeneron Pharmaceuticals Inc (NASDAQ:REGN), following the news that Regeneron’s Praluent, the …
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA (ADR) (NYSE:SNY) announced that the Phase 3 ODYSSEY JAPAN trial of the investigational therapy Praluent® (alirocumab) Injection …
In a research report issued today, Piper Jaffray analyst Edward Tenthoff weighed in with a few insights on Regeneron Pharmaceuticals Inc (NASDAQ:REGN) following Avalanche’s …
RBC Capital analyst Adnan Butt was out pounding the table with Regeneron Pharmaceuticals Inc (NASDAQ:REGN), reiterating an Outperform rating on the stock and boosting the price …
In a research report released Wednesday, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on Regeneron Pharmaceuticals Inc (NASDAQ:REGN) with a $525 price target, …
RBC Capital analyst Adnan Butt came out with a research report on Regeneron Pharmaceuticals Inc (NASDAQ:REGN) following an FDA panel recommendation for the approval of Regeneron …
CTI BioPharma Corp (NASDAQ:CTIC) shares increased 9.6% to $2.
